406 related articles for article (PubMed ID: 31585275)
41. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
[TBL] [Abstract][Full Text] [Related]
42. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
43. Multidrug resistance reversal activity of key ningalin analogues.
Soenen DR; Hwang I; Hedrick MP; Boger DL
Bioorg Med Chem Lett; 2003 May; 13(10):1777-81. PubMed ID: 12729663
[TBL] [Abstract][Full Text] [Related]
44. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
45. Jatrophane diterpenoids from Euphorbia sororia as potent modulators against P-glycoprotein-based multidrug resistance.
Hu R; Gao J; Rozimamat R; Aisa HA
Eur J Med Chem; 2018 Feb; 146():157-170. PubMed ID: 29407947
[TBL] [Abstract][Full Text] [Related]
46. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
47. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
[TBL] [Abstract][Full Text] [Related]
48. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
Chen LM; Liang YJ; Zhang X; Su XD; Dai CL; Wang FP; Yan YY; Tao LY; Fu LW
Anticancer Res; 2009 Nov; 29(11):4597-604. PubMed ID: 20032409
[TBL] [Abstract][Full Text] [Related]
49. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
[TBL] [Abstract][Full Text] [Related]
50. Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships.
Umsumarng S; Pitchakarn P; Yodkeeree S; Punfa W; Mapoung S; Ramli RA; Pyne SG; Limtrakul P
Phytomedicine; 2017 Oct; 34():182-190. PubMed ID: 28899501
[TBL] [Abstract][Full Text] [Related]
51. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
[TBL] [Abstract][Full Text] [Related]
52. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
[TBL] [Abstract][Full Text] [Related]
53. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
55. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
[TBL] [Abstract][Full Text] [Related]
56. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
[TBL] [Abstract][Full Text] [Related]
57. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
58. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
Xu HB; Li L; Fu J; Mao XP; Xu LZ
Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
[TBL] [Abstract][Full Text] [Related]
59. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
60. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
Liu RM; Xu P; Chen Q; Feng SL; Xie Y
Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
